Liabilities and Equity of Organon & Co. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Organon & Co. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Organon & Co. Liabilities and Equity for the quarter ending 31 Dec 2025 was $12,867,000,000, a 1.8% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Organon & Co. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $12,867,000,000 -$234,000,000 -1.8% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $13,552,000,000 +$800,000,000 +6.3% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $13,500,000,000 +$1,346,000,000 +11% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $13,156,000,000 +$1,265,000,000 +11% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $13,101,000,000 +$1,043,000,000 +8.6% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $12,752,000,000 +$1,740,000,000 +16% 30 Sep 2024 10-Q 01 Nov 2024 2024 Q3
Q2 2024 $12,154,000,000 +$1,175,000,000 +11% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $11,891,000,000 +$1,128,000,000 +10% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $12,058,000,000 +$1,103,000,000 +10% 31 Dec 2023 10-K/A 10 Nov 2025 2024 FY
Q3 2023 $11,012,000,000 +$575,000,000 +5.5% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $10,979,000,000 +$365,000,000 +3.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $10,763,000,000 +$166,000,000 +1.6% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $10,955,000,000 +$274,000,000 +2.6% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $10,437,000,000 -$898,000,000 -7.9% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $10,614,000,000 -$294,000,000 -2.7% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $10,597,000,000 +$955,000,000 +9.9% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $10,681,000,000 +$572,000,000 +5.7% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $11,335,000,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $10,908,000,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $9,642,000,000 31 Mar 2021 10-Q 21 Jun 2021 2021 Q1
Q4 2020 $10,109,000,000 31 Dec 2020 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.